Takeda takes another step into India with Advinus R&D alliance
This article was originally published in Scrip
Executive Summary
There has long been speculation that Takeda may be in line for a commercial acquisition in India, but for the time being at least Asia's largest pharma firm has opted for the collaborative R&D approach.
You may also be interested in...
Takeda-Advinus R&D Alliance ‘Closed’
Takeda’s alliance with Advinus Therapeutics, a much-touted deal that had put the spotlight on the Indian R&D services firm, has ended. Advinus is currently in the process of divesting of its contract research business to Eurofins Scientific.
Will Eurofins Deal See Advinus Turn The Corner?
Eurofins Scientific has snapped up the contract research business of Advinus Therapeutics, continuing its ongoing acquisition momentum. The deal also ends long-running speculation around a potential sale of Advinus, amid its rocky recent run.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.